Alleviation of Hyperuricemia by Strictinin in AML12 Mouse Hepatocytes Treated with Xanthine and in Mice Treated with Potassium Oxonate

SIMPLE SUMMARY: Hyperuricemia is a major risk factor for gout. Inhibition of liver xanthine oxidase has been shown to reduce the uric acid level in blood. However, side effects were reported for the xanthine oxidase inhibitors clinically used in the treatment of hyperuricemia. This study aimed to ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Kuo-Ching, Chang, Yu-Ting, Pranata, Rosita, Cheng, Yung-Hsuan, Chen, Yu-Chi, Kuo, Ping-Chung, Huang, Yi-Hsuan, Tzen, Jason T. C., Chen, Rong-Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953564/
https://www.ncbi.nlm.nih.gov/pubmed/36829604
http://dx.doi.org/10.3390/biology12020329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953564/
https://www.ncbi.nlm.nih.gov/pubmed/36829604
http://dx.doi.org/10.3390/biology12020329

Ejemplares similares